Form 10 Explorer
10-Q
Quarterly Report
VITASPRING BIOMEDICAL CO., LTD.

CIK: 1697884

File #: 333-216645

Period End: Apr 30, 2024

Fiscal Year: 2025

View on EDGAR
Balance Sheet
27 line items · 2 periods
XBRL
ItemApr 30, 2024Jan 31, 2024
BALANCE SHEETS
ASSETS
CURRENT ASSETS
Cash
96813
Other Non-Operating Current Assets
39,7250
Other Current Assets
23,61423,614
Total current assets
64,30723,627
LONG-TERM ASSETS
Property, Plant and Equipment
21,57424,063
Operating Lease Right-of-Use Asset
45,40789,652
Total long-term assets
66,981113,715
Total assets
131,288137,342
LIABILITIES AND STOCKHOLDERS' DEFICIT
CURRENT LIABILITIES
Accounts Payable
2,411,0002,411,000
Other Non-Operating Current Liabilities
279,056339,001
Taxes Payable
218,714218,714
Operating Lease Liability, Current
47,24893,334
Advance from related party
701,073425,482
Current liabilities and total liabilities
3,657,0913,487,531
COMMITMENTS AND CONTINGENCIES
00
STOCKHOLDERS' DEFICIT
Total Stockholders' Equity
20,70320,703
Total Stockholders' Equity
1,176,9061,135,689
Total Stockholders' Equity
(4,723,412)(4,506,581)
Total stockholders' deficit
(3,525,803)(3,350,189)
Total liabilities and stockholders' deficit
131,288137,342